Rare canine aortic chondrosarcoma diagnosed by transarterial biopsy: full analysis
Version 2
A case report newly published in the Journal of Small Animal Practice details the diagnosis of an intraluminal aortic chondrosarcoma in a dog via transarterial biopsy, followed by treatment with stereotactic body radiation therapy, offering a rare look at how clinicians may approach a tumor in one of the most difficult anatomic locations in small animal practice. In the reported case, the patient was a 2-year-old Flat Coated Retriever whose aortic mass was found incidentally on CT, later confirmed histopathologically after catheter-based biopsy, and managed with SBRT rather than surgery. (synapsesocial.com)
That matters in part because primary tumors of the great vessels are exceptionally uncommon in dogs. Earlier veterinary reports have described only isolated cases of aortic chondrosarcoma or other intimal sarcomas, including a prior report that characterized aortic chondrosarcoma as only the second such case documented in a dog, and another that described primary intimal aortic angiosarcoma as the first of its kind with endothelial immunohistochemical evidence in a veterinary species. Taken together, the literature suggests clinicians are still operating with case-report-level evidence when these lesions appear. (sciencedirect.com)
In this new report, the lesion was observed to enlarge on repeat CT before clinicians pursued biopsy through right femoral artery catheterization using endoscopic biopsy forceps. Histopathology confirmed chondrosarcoma. The dog then received SBRT at 24 Gy total, delivered as 8 Gy in three fractions every other day. According to the report summary, there were no adverse effects attributed to either the biopsy procedure or the initial radiation course. Imaging at five months showed stable disease, but progression was noted at eight months, prompting a second round of the same SBRT protocol. The dog remained clinically well for a period afterward, then presented 84 days later with signs of multiple organ dysfunction syndrome and was euthanized. (synapsesocial.com)
While no direct outside commentary on this specific paper was readily available, related veterinary literature helps frame why the approach is drawing attention. A prior case report described fluoroscopically guided endovascular biopsy of an intracardiac paraganglioma in a dog, supporting the broader idea that catheter-based sampling can be a workable option when open biopsy is impractical or risky. Separately, retrospective reports on SBRT for canine heart-base tumors have suggested the modality can be delivered with relatively low rates of normal-tissue complications and may provide meaningful disease control in selected patients, even though those data largely come from tumor types such as chemodectomas rather than primary aortic sarcomas. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary teams, this case is less about establishing a standard of care than about expanding the procedural playbook for rare vascular tumors. The report suggests that a definitive diagnosis may sometimes be achievable without thoracotomy, which could help guide prognosis, referral decisions, radiation planning, and conversations with a pet parent about risk and expected benefit. It also underscores the likely ceiling of current therapy: even with technically successful biopsy and an initial period of stable disease after SBRT, progression still occurred within months. That makes this an important proof-of-concept case, but not yet a signal that local therapy alone can meaningfully alter long-term outcomes for canine aortic sarcoma. (synapsesocial.com)
The case may also be useful for specialists thinking across disciplines. Interventional radiology, cardiology, medical oncology, radiation oncology, and diagnostic imaging all intersected here, and that kind of collaboration is likely to be essential whenever an intraluminal great-vessel mass is discovered. For general practitioners, the practical takeaway is narrower but still important: an incidental vascular lesion on advanced imaging may warrant referral, because diagnosis and treatment options may exist even when the anatomy looks prohibitive. (synapsesocial.com)
What to watch: The next step for the field will be whether additional published cases clarify complication rates, case selection, radiation response duration, and whether repeat SBRT or multimodal therapy can improve outcomes in dogs with primary aortic sarcomas rather than more common heart-base tumors. For now, this report adds a useful data point to a very small evidence base. (sciencedirect.com)